Nice post! Here is the excerpt; ToleroTech Inc a
Post# of 5066
ToleroTech Inc and Bio-Matrix Scientific Group Inc are developing small interfering (si)RNA-based cancer vaccines designed to treat cancer by silencing immunosuppressive molecules such as IDO. While Tolerotech is evaluating the value of these agents in melanoma, Bio-Matrix is focusing on breast cancer. - See more at: http://www.onclive.com/publications/oncology-...YDP7S.dpuf
This is getting ready to blow off the hook! Thanks for the post "Dream"